American Society of Hirudotherapy

Publication Tracker — ASH

Live timeline of 9766 PMID-verified articles ASH tracks. Filter by category to explore the literature growth toward our 10,000-paper coverage goal.

Last Updated: May 27, 2026Reviewed by: Andrei Dokukin, MD
Literature surveillanceEditorial reference — not clinical advice

This page is the public face of ASH's literature-tracking pipeline. Every entry here is parsed from PubMed metadata directly, cross-checked against the article's real PMID, and committed into the open-source registry behind this site. Hand-curated registries are tracked separately at PMID Audit Status.

The corpus grows continuously as new PubMed-indexed hirudotherapy and leech-derived-compound papers are published. The 10,000-article goal is the coverage threshold needed to consider ASH's literature surveillance comprehensive across all leech-related biomedical sub-fields.

9766

Total tracked articles

PMID-verified, auto-imported from PubMed

1767

Added in last 12 months

Rolling window ending 2026-05-27

97.7%

Progress toward 10,000-paper goal

Filter by category

Timeline by publication year

2026

969 articlesCurrent year
Clinical Literature2026PMID 41813170

Cancer-associated thrombosis presenting as multiple brain infarctions during complete remission of follicular lymphoma

Tokura et al. · Internal medicine (Tokyo, Japan)

Added to ASH registry: 2026-05-29

Clinical Literature2026PMID 42148071

Catastrophic antiphospholipid syndrome complicated with multiple infections: a case report

Zhou et al. · Frontiers in immunology

Added to ASH registry: 2026-05-29

Clinical Literature2026PMID 41773593

Comparing Efficacy and Safety of Different Anticoagulants in Cerebral Venous Thrombosis: A Systematic Review and Network Meta-Analysis

Waseem et al. · Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Added to ASH registry: 2026-05-29

Drug Development2026PMID 42161432

Comparison of aspirin and rivaroxaban for the prevention of pulmonary embolism and deep vein thrombosis in high thrombotic risk patients with systemic lupus erythematosus: study protocol for a multicentre, prospective, randomised controlled trial

Zhang et al. · Lupus science & medicine

Added to ASH registry: 2026-05-29

Clinical Literature2026PMID 41738754

Comparison of Bleeding Risks and All-Cause Death Between Warfarin and Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Obstructive Pulmonary Disease: A Multicenter Retrospective Cohort Study

Zhao et al. · Chronic obstructive pulmonary diseases (Miami, Fla.)

Added to ASH registry: 2026-05-29

Clinical Literature2026PMID 42190734

Comparison of people with hemophilia A and patients with non-valvular atrial fibrillation on oral anticoagulation by thrombin generation

Kraemmer et al. · Thrombosis and haemostasis

Added to ASH registry: 2026-05-29

Drug Development2026PMID 42007131

Dabigatran outperforms warfarin in elderly patients with atrial fibrillation and stable coronary artery disease: reduced risks of bleeding and cardiovascular events

Song et al. · American journal of translational research

Added to ASH registry: 2026-05-29

Drug Development2026PMID 41717124

Dabigatran-induced acute hepatitis in a patient with atrial fibrillation: a rare case report

Hsu et al. · European heart journal. Case reports

Added to ASH registry: 2026-05-29

Clinical Literature2026PMID 41634587

Direct oral anticoagulants versus vitamin K antagonists for postoperative atrial fibrillation after cardiac surgery: a systematic review and meta-analysis of randomized controlled trials

Ahmed et al. · BMC cardiovascular disorders

Added to ASH registry: 2026-05-29

Drug Development2026PMID 41660516

Edoxaban for stroke prevention in Chinese patients with atrial fibrillation: 1-year follow-up of the ETNA-AF-China study

Guo et al. · Frontiers in pharmacology

Added to ASH registry: 2026-05-29

Drug Development2026PMID 41338415

Edoxaban for stroke prevention in patients with atrial fibrillation: Of randomized and real-world evidence

de · Indian pacing and electrophysiology journal

Added to ASH registry: 2026-05-29

Drug Development2026PMID 40756205

Edoxaban-induced enterocolitis: The first case report demonstrating distinct endoscopic and histological features

Endo et al. · DEN open

Added to ASH registry: 2026-05-29

Safety & Infection Control2026PMID 41592270

Effect of Postoperative Medication on Range of Motion After Total Knee Arthroplasty: An Evaluation of Venous Thromboembolism Chemoprophylaxis

Kirwood et al. · The Journal of the American Academy of Orthopaedic Surgeons

Added to ASH registry: 2026-05-29

Clinical Literature2026PMID 41790331

Efficacy and safety of direct oral anticoagulants and low molecular weight heparin for cancer-associated venous thromboembolism in patients with extremes in bodyweight

Toale et al. · Journal of thrombosis and thrombolysis

Added to ASH registry: 2026-05-29

Drug Development2026PMID 40879867

Efficacy and safety of reduced-dose versus full-dose DOACs in extended treatment of VTE: A systematic review and meta-analysis

Bilal et al. · Journal of thrombosis and thrombolysis

Added to ASH registry: 2026-05-29

Drug Development2026PMID 41933143

Efficacy of argatroban plus alteplase versus intravenous alteplase according to diabetes mellitus in acute ischemic stroke

Hou et al. · Scientific reports

Added to ASH registry: 2026-05-29

Drug Development2026PMID 42140238

Extended Rivaroxaban Therapy for Cancer-Associated Low-Risk Pulmonary Embolism by Chemotherapy Status: Insights from the ONCO PE Trial

Xiong et al. · Thrombosis and haemostasis

Added to ASH registry: 2026-05-29

Clinical Literature2026PMID 41646621

Navigating Perioperative Anticoagulation Challenges in a Cancer Patient With Deep Vein Thrombosis: A Case Report

Binoy et al. · Cureus

Added to ASH registry: 2026-05-29

Clinical Literature2026PMID 42105519

Open-tubular affinity capillary electrochromatography with MOF-caged thrombin: Effective mobility ratio strategy for anticoagulant screening in complex systems

Fu et al. · Talanta

Added to ASH registry: 2026-05-29

Clinical Literature2026PMID 42206789

Oral Anticoagulants and Risk of Bleeding and Death in Cancer-Associated Venous Thromboembolism

Lutsey et al. · JACC. Advances

Added to ASH registry: 2026-05-29

Drug Development2026PMID 41084371

Peak and Trough Concentration Ranges of Factor Xa Inhibitors for Preventing Thromboembolic Stroke in Korean Patients with Non-valvular Atrial Fibrillation

Park et al. · Annals of laboratory medicine

Added to ASH registry: 2026-05-29

Drug Development2026PMID 41652091

Pharmacogenomic profiling of ABCB1 and CES1 in atrial fibrillation patients on dabigatran from a multiethnic Malaysian cohort

Tan et al. · Scientific reports

Added to ASH registry: 2026-05-29

Clinical Literature2026PMID 41658977

Prevalence of abnormal uterine bleeding and quality of life after venous thromboembolism by oral anticoagulant use: the GENB-OAC Study

Sarlon-Bartoli et al. · Research and practice in thrombosis and haemostasis

Added to ASH registry: 2026-05-29

Drug Development2026PMID 41243623

Real-World Edoxaban Concentrations in Older Patients Receiving Reduced-Dose Regimens

Tang et al. · Clinical pharmacology and therapeutics

Added to ASH registry: 2026-05-29

Clinical Literature2026PMID 41522040

Relationship between vascular calcification assessed by chest CT and CHA(2)DS(2)-VASc score in patients with atrial fibrillation receiving oral anticoagulant

Wu et al. · Quantitative imaging in medicine and surgery

Added to ASH registry: 2026-05-29

Drug Development2026PMID 41913993

Reversal of Progressive In-Hospital Posterior Artery-to-Artery Embolic Stroke With Argatroban: A Case Report

She et al. · British journal of hospital medicine (London, England : 2005)

Added to ASH registry: 2026-05-29

Clinical Literature2026PMID 41640908

Severe Arterial Thrombosis Revealing Underlying Nephrotic Syndrome

Prakash et al. · Cureus

Added to ASH registry: 2026-05-29

Clinical Literature2026PMID 41607628

Subclinical atrial fibrillation: Implications of recent trials for guideline updates?

Pradhan et al. · World journal of cardiology

Added to ASH registry: 2026-05-29

Clinical Literature2026PMID 42111052

Superficial vein thrombosis of the upper extremity after pectoralis major repair: An uncommon complication

Helal et al. · Trauma case reports

Added to ASH registry: 2026-05-29

Drug Development2026PMID 42024702

Total Clinical Event Burden with Edoxaban Monotherapy versus Dual Antithrombotic Therapy in Atrial Fibrillation and Stable Coronary Artery Disease: Insights from the EPIC-CAD Trial

Kim et al. · Journal of the American Heart Association

Added to ASH registry: 2026-05-29

Clinical Literature2026PMID 42110046

Upper Extremity Deep Vein Thrombosis Secondary to Gastric Cancer: A Case Report

Takano et al. · Cureus

Added to ASH registry: 2026-05-29

Clinical Literature2026PMID 41580730

Use of resources and cost in the management of gastrointestinal hemorrhage caused by oral anticoagulants: a retrospective cohort analysis

Machado-Duque et al. · Cost effectiveness and resource allocation : C/E

Added to ASH registry: 2026-05-29

Clinical Literature2026PMID 41822528

"Preventing vision loss in pediatric otogenic thrombosis: a case report highlighting surgical interventions"

AlMuhanna FA et al. · Frontiers in ophthalmology

Added to ASH registry: 2026-05-28

Antimicrobial Resistance2026PMID 42023620

[Translated article] Soft tissue infections during a climate emergency: Impact of the October 2024 cut-off low (DANA) event in Valencia.

Amaya Franco A et al. · Revista espanola de cirugia ortopedica y traumatologia

Added to ASH registry: 2026-05-28

Clinical Literature2026PMID 41825067

10-Year Experience of Hybrid DIEP with Implant Breast Reconstruction: Univariate Analyses of Risk Factors Associated with Flap Failure

Lohasammakul et al. · Plastic and reconstructive surgery

Added to ASH registry: 2026-05-28

Clinical Literature2026PMID 42092507

2026 American Association for Thoracic Surgery (AATS) Expert Consensus Document: Diagnosis and management of heparin-induced thrombocytopenia in cardiac surgery patients

Chatterjee et al. · The Journal of thoracic and cardiovascular surgery

Added to ASH registry: 2026-05-28

Clinical Literature2026PMID 41247175

3D Head-Up Display Exoscope: An Ergonomic and Portable Alternative for Microsurgery

Kim et al. · Plastic and reconstructive surgery

Added to ASH registry: 2026-05-28

Clinical Literature2026PMID 42003987

3D printing-guided chest wall reconstruction - a case report and literature review

Yoon et al. · JPRAS open

Added to ASH registry: 2026-05-28

Clinical Literature2026PMID 41655786

A 25-year evaluation of direct local international normalized ratio calibration of the Owren type prothrombin time method in Sweden

Hillarp et al. · Journal of thrombosis and haemostasis : JTH

Added to ASH registry: 2026-05-28

Clinical Literature2026PMID 41584394

A Bear of a Case: Multidisciplinary Reconstruction Following a Grizzly Bear Mauling

Beiriger et al. · Clinical case reports

Added to ASH registry: 2026-05-28

Showing 40 of 969. The full list is in the research library.

2025

1369 articles
Clinical Literature2025PMID 40535145

A Case of Surgery for a Giant Popliteal Venous Aneurysm Positive for Heparin-Induced Thrombocytopenia Antibodies with Repeated Acute Pulmonary Embolism

Tomita et al. · Annals of vascular diseases

Added to ASH registry: 2026-05-29

Drug Development2025PMID 40580411

A Cost-Effectiveness Analysis of Rivaroxaban Compared to Warfarin for the Management of Venous Thromboembolism in Western Kenya

O'Neill et al. · Clinical drug investigation

Added to ASH registry: 2026-05-29

Safety & Infection Control2025PMID 40462882

A Protocol for Venous Thromboembolism Prophylaxis in Elective Spine Surgery: A Retrospective Evaluation of a Single-Center Experience

Aljohani et al. · Cureus

Added to ASH registry: 2026-05-29

Drug Development2025PMID 40503992

Administration of decapsulated dabigatran via nasogastric tube: A case report

Kaneta et al. · American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

Added to ASH registry: 2026-05-29

Clinical Literature2025PMID 40895096

An efficient approach for detecting atrial fibrillation in ischemic stroke patients using a wearable device: a prospective multicenter substudy of the STABLED trial

Saito et al. · Frontiers in neurology

Added to ASH registry: 2026-05-29

Drug Development2025PMID 40825054

Analysis of hemorrhagic transformation and intracerebral hemorrhage under combination therapy with alteplase and antiplatelets or anticoagulants, using the Japanese Adverse Drug Event Report database

Nakai et al. · PloS one

Added to ASH registry: 2026-05-29

Clinical Literature2025PMID 40486638

Anticoagulation strategies for stroke prevention in atrial fibrillation: a comprehensive review of current literature

Castro-Vidal et al. · Annals of medicine and surgery (2012)

Added to ASH registry: 2026-05-29

Clinical Literature2025PMID 41154640

Anticoagulation Therapies and microRNAs in Heart Failure

Spartano et al. · Biomolecules

Added to ASH registry: 2026-05-29

Genomics & Proteomics2025PMID 40020462

Argatroban and Menadione exert protective effects in ultraviolet-irradiated skin inflammation: A transcriptomic analysis based on identification of iron overload related biomarkers

Lv et al. · International immunopharmacology

Added to ASH registry: 2026-05-29

Drug Development2025PMID 39675018

Argatroban plus alteplase in posterior versus anterior circulation stroke

Cui et al. · Annals of clinical and translational neurology

Added to ASH registry: 2026-05-29

Drug Development2025PMID 40375365

Argatroban plus dual antiplatelet therapy versus dual antiplatelet alone for acute atherothrombotic cerebral infarction

Nakashima et al. · International journal of stroke : official journal of the International Stroke Society

Added to ASH registry: 2026-05-29

Drug Development2025PMID 40530546

Association Between Argatroban and Outcomes of Branch Atheromatous Disease: A Propensity-Matched Analysis From MRI-Based Study

Li et al. · CNS neuroscience & therapeutics

Added to ASH registry: 2026-05-29

Drug Development2025PMID 40470653

Association of Genetic Variants With Rivaroxaban Pharmacokinetics and Pharmacodynamics and Hemorrhage Risk Factors in Patients With Venous Thromboembolism

Li et al. · Journal of the American Heart Association

Added to ASH registry: 2026-05-29

Drug Development2025PMID 39495065

Biological Variation of Hemostasis Analytes in Atrial Fibrillation Patients Using Dabigatran

Tilly et al. · The journal of applied laboratory medicine

Added to ASH registry: 2026-05-29

Drug Development2025PMID 40827076

Bleeding risk among cancer patients receiving concurrent CYP-interacting tyrosine kinase inhibitors with direct oral anticoagulants versus alternative anticoagulation therapies

Tan et al. · Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Added to ASH registry: 2026-05-29

Drug Development2025PMID 40738682

Bleeding Risk in the Early Postoperative Period after Atrial Fibrillation Ablation with Anticoagulant Therapy Using Dabigatran Etexilate

Takashima et al. · Biological & pharmaceutical bulletin

Added to ASH registry: 2026-05-29

Clinical Literature2025PMID 40833918

Bleeding risk using non-steroidal anti-inflammatory drugs in anticoagulated patients with atrial fibrillation: a nationwide cohort study

Petersen et al. · European heart journal. Quality of care & clinical outcomes

Added to ASH registry: 2026-05-29

Clinical Literature2025PMID 40697425

Catastrophic asparaginase-induced cerebral and systemic thrombosis in a young female with T-cell lymphoblastic lymphoma: A case report & literature review

Ahmed et al. · Leukemia research reports

Added to ASH registry: 2026-05-29

Clinical Literature2025PMID 39748410

Clinical effectiveness and safety comparison between direct oral anticoagulants and warfarin for nonvalvular atrial fibrillation patients following percutaneous left atrial appendage closure operation intervention: a prospective observational study

Yao et al. · BMC pharmacology & toxicology

Added to ASH registry: 2026-05-29

Clinical Literature2025PMID 41022159

Clinical impact of kidney function in patients with atrial fibrillation receiving oral anticoagulants

Matsuoka et al. · International journal of cardiology

Added to ASH registry: 2026-05-29

Clinical Literature2025PMID 40868945

Clinical Outcomes of Oral Anticoagulation in Elderly East Asian Patients with Atrial Fibrillation: A Retrospective Single-Center Study

Kim et al. · Life (Basel, Switzerland)

Added to ASH registry: 2026-05-29

Clinical Literature2025PMID 40970015

Clinical Perspectives on Stroke Prevention in Patients with Non-valvular Atrial Fibrillation in the Philippines

Jimenez et al. · Cureus

Added to ASH registry: 2026-05-29

Clinical Literature2025PMID 40395561

Comparative Analysis of the Net Clinical Benefit of Direct Oral Anticoagulants in Atrial Fibrillation: Systematic Review and Network Meta-analysis of Randomised Controlled Trials

Duy Mai et al. · European cardiology

Added to ASH registry: 2026-05-29

Clinical Literature2025PMID 40822463

Comparative clinical outcomes of acenocoumarol versus direct oral anticoagulants (DOACs) and warfarin in patients with atrial fibrillation: real-world-evidence (SIESTA-A study)

Montero-Balosa et al. · Frontiers in pharmacology

Added to ASH registry: 2026-05-29

Clinical Literature2025PMID 39215489

Comparative effectiveness and safety of direct oral anticoagulants and warfarin in atrial fibrillation patients with dementia

Fang et al. · European stroke journal

Added to ASH registry: 2026-05-29

Clinical Literature2025PMID 40311503

Comparative effectiveness and safety of direct oral anticoagulants in atrial fibrillation patients with dementia

Fang et al. · Thrombosis research

Added to ASH registry: 2026-05-29

Clinical Literature2025PMID 40923313

Comparative Effectiveness of Direct Oral Anticoagulants and Warfarin on Venous Thromboembolism in Cancer Patients

Jung et al. · Cancer medicine

Added to ASH registry: 2026-05-29

Clinical Literature2025PMID 40714858

Comparative Risk of Major Bleeding With Concomitant Use of Oral Anticoagulants and Corticosteroid Bursts

Yao et al. · Clinical and translational science

Added to ASH registry: 2026-05-29

Clinical Literature2025PMID 40995802

Comparative safety and effectiveness of direct oral anticoagulants and warfarin in patients with venous thromboembolism in Finland, Norway and Sweden

Ghanima et al. · Journal of comparative effectiveness research

Added to ASH registry: 2026-05-29

Clinical Literature2025PMID 39841678

Comparative safety and effectiveness of oral anticoagulants in key subgroups of patients with non-valvular atrial fibrillation and at high risk of gastrointestinal bleeding: A cohort study based on the French National Health Data System (SNDS)

Lip et al. · PloS one

Added to ASH registry: 2026-05-29

Safety & Infection Control2025PMID 40584925

Comparison of Acetylsalicylic Acid with Rivaroxaban or Alternative Anticoagulants for Thromboprophylaxis in Elective Total Hip Arthroplasty: A Retrospective Cohort Study

Norman et al. · The Canadian journal of hospital pharmacy

Added to ASH registry: 2026-05-29

Safety & Infection Control2025PMID 42038854

Comparison of Efficacy and Safety of Rivaroxaban, Heparin, and Enoxaparin in Preventing Thrombosis in Gynaecologic Oncology Surgeries : Thromboprophylaxis in Gyn-oncology Surgery

Saffarieh et al. · Galen medical journal

Added to ASH registry: 2026-05-29

Safety & Infection Control2025PMID 40524197

Comparison of VTE prophylaxis agents on hemoglobin levels after total knee arthroplasty: a hospital information system-based observational study

Yuan et al. · Journal of orthopaedic surgery and research

Added to ASH registry: 2026-05-29

Clinical Literature2025PMID 41057675

Cost Differences Between Oral Anticoagulation Therapies in Patients with Atrial Fibrillation in Finland

Lehtonen et al. · Drugs - real world outcomes

Added to ASH registry: 2026-05-29

Drug Development2025PMID 39918252

Cost-effectiveness of apixaban in non-valvular atrial fibrillation (NVAF) based on effectiveness data from a Spanish study in clinical practice (real-world evidence)

Anguita et al. · Expert review of cardiovascular therapy

Added to ASH registry: 2026-05-29

Safety & Infection Control2025PMID 40851672

Cost-Effectiveness Thresholds for Venous Thromboembolism Prophylaxis in Ankle Fracture Surgery: A Break-Even Analysis

Mody et al. · Foot & ankle orthopaedics

Added to ASH registry: 2026-05-29

Drug Development2025PMID 39586831

Dabigatran Attenuates the Binding of Thrombin to Platelets-A Novel Mechanism of Action

Lindahl et al. · Thrombosis and haemostasis

Added to ASH registry: 2026-05-29

Clinical Literature2025PMID 40364283

Demographic and Socio-Economic Disparities in the Outcomes Among Patients with NVAF Treated with Oral Anticoagulants: A Real-World Evaluation of Medicare Beneficiaries

Atreja et al. · Journal of clinical medicine

Added to ASH registry: 2026-05-29

Clinical Literature2025PMID 40634145

Deterioration of renal function is delayed in patients with atrial fibrillation treated with direct oral anticoagulants compared to vitamin K antagonists: systematic review and meta-analysis

Adamou et al. · European journal of internal medicine

Added to ASH registry: 2026-05-29

Clinical Literature2025PMID 40565590

Direct Oral Anticoagulant-Related Bleeding in Atrial Fibrillation Patients Leads to ADAMTS7 Promoter Demethylation

Ragia et al. · Genes

Added to ASH registry: 2026-05-29

Showing 40 of 1369. The full list is in the research library.

2024

865 articles
Clinical Literature2024PMID 39629256

A case of pulmonary vein thrombosis with transient ischemic attacks diagnosed by contrast-enhanced computed tomography

Ogata et al. · Respirology case reports

Added to ASH registry: 2026-05-29

Drug Development2024PMID 39359641

A comparative study of the clinical benefits of rivaroxaban and dabigatran in patients with nonvalvular atrial fibrillation with high bleeding risk

Liu · Frontiers in cardiovascular medicine

Added to ASH registry: 2026-05-29

Drug Development2024PMID 38889295

Adverse events of direct factor Xa inhibitors: a disproportionality analysis of the FAERS database

Qian et al. · Expert opinion on drug safety

Added to ASH registry: 2026-05-29

Clinical Literature2024PMID 38334914

Age-related variation in coagulation factors in non-valvular atrial fibrillation patients receiving direct oral anticoagulants

Kumano et al. · International journal of hematology

Added to ASH registry: 2026-05-29

Clinical Literature2024PMID 39222018

Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trials

Schnabel et al. · European heart journal

Added to ASH registry: 2026-05-29

Drug Development2024PMID 39133474

Apixaban vs Aspirin in Patients With Cancer and Cryptogenic Stroke: A Post Hoc Analysis of the ARCADIA Randomized Clinical Trial

Navi et al. · JAMA neurology

Added to ASH registry: 2026-05-29

Drug Development2024PMID 38828563

Application of the Win Ratio Method in the ENGAGE AF-TIMI 48 Trial Comparing Edoxaban With Warfarin in Patients With Atrial Fibrillation

Bergmark et al. · Circulation. Cardiovascular quality and outcomes

Added to ASH registry: 2026-05-29

Drug Development2024PMID 39314834

Appropriateness of direct oral anticoagulant dosing in patients with atrial fibrillation at a tertiary care hospital in Thailand

Pongsathabordee et al. · Exploratory research in clinical and social pharmacy

Added to ASH registry: 2026-05-29

Drug Development2024PMID 37934717

Argatroban Use in Pediatric Patients Supported by Paracorporeal Ventricular Assist Devices

Tuttle et al. · ASAIO journal (American Society for Artificial Internal Organs : 1992)

Added to ASH registry: 2026-05-29

Clinical Literature2024PMID 39303835

Assessing methods to ascertain persistence and adherence of oral anticoagulants in patients with atrial fibrillation

Tan et al. · American heart journal

Added to ASH registry: 2026-05-29

Clinical Literature2024PMID 39121298

Association between 24-hour blood pressure parameters and 90-day functional outcome in acute ischemic stroke patients with early anticoagulation

Hu et al. · Medicine

Added to ASH registry: 2026-05-29

Clinical Literature2024PMID 39296588

Association of direct oral anticoagulants and warfarin with incidence of dementia in atrial fibrillation patients: A systematic review and meta-analysis

Zhang et al. · International journal of cardiology. Heart & vasculature

Added to ASH registry: 2026-05-29

Drug Development2024PMID 39406013

Bivalirudin for unsalvageable venous congestion or obstruction in head and neck free flap reconstruction

Harris et al. · Oral oncology

Added to ASH registry: 2026-05-29

Drug Development2024PMID 38157869

Bivalirudin Stability in Citrated Plasma and Citrated Whole Blood

Bruzdoski et al. · Archives of pathology & laboratory medicine

Added to ASH registry: 2026-05-29

Drug Development2024PMID 38440919

Bivalirudin: The misunderstood alternative to heparin

Faraoni et al. · Paediatric anaesthesia

Added to ASH registry: 2026-05-29

Clinical Literature2024PMID 39494558

Bleeding Associated With Antiarrhythmic Drugs in Patients With Atrial Fibrillation Using Direct Oral Anticoagulants: A Nationwide Population Cohort Study

Wu et al. · Journal of the American Heart Association

Added to ASH registry: 2026-05-29

Drug Development2024PMID 38412157

Can the combination of antiplatelet or alteplase thrombolytic therapy with argatroban benefit patients suffering from acute stroke? a systematic review, meta-analysis, and meta-regression

Xie et al. · PloS one

Added to ASH registry: 2026-05-29

Clinical Literature2024PMID 39382062

CHA(2)DS(2)-VASc score and prior oral anticoagulant use on endovascular treatment for acute ischemic stroke

Imaoka et al. · Annals of clinical and translational neurology

Added to ASH registry: 2026-05-29

Clinical Literature2024PMID 39797177

Characteristics of Gastrointestinal Bleeding While Taking Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation and Differences Among Drugs-A Single-Center Retrospective Cohort Study

Aoki et al. · Journal of clinical medicine

Added to ASH registry: 2026-05-29

Drug Development2024PMID 39046333

Clinical Implications of Co-administering Apixaban with Key Interacting Medications

Favatella et al. · Clinical pharmacology in drug development

Added to ASH registry: 2026-05-29

Drug Development2024PMID 38556764

Comment on: Bivalirudin during thrombolysis with catheter-directed tPA in a heparin-refractory patient: A case report

Han · Pediatric blood & cancer

Added to ASH registry: 2026-05-29

Clinical Literature2024PMID 39370117

Comparative Effectiveness and Safety of Direct Oral Anticoagulants vs Warfarin among Nursing Home Residents with Atrial Fibrillation: A Retrospective Cohort Study

Mehta et al. · Journal of the American Medical Directors Association

Added to ASH registry: 2026-05-29

Clinical Literature2024PMID 38437952

Comparative effectiveness of factor Xa non-vitamin K antagonist oral anticoagulants versus phenprocoumon in patients with non-valvular atrial fibrillation

Kreutz et al. · International journal of cardiology

Added to ASH registry: 2026-05-29

Clinical Literature2024PMID 39546473

Comparative safety and effectiveness of oral anticoagulants in patients with non-valvular atrial fibrillation and high risk of gastrointestinal bleeding: A nationwide French cohort study

Lip et al. · PloS one

Added to ASH registry: 2026-05-29

Clinical Literature2024PMID 38510285

Comparing Anticoagulation Strategies for Venous Thromboembolism Associated With Active Cancer: A Systematic Review and Meta-Analysis

Fujisaki et al. · JACC. CardioOncology

Added to ASH registry: 2026-05-29

Drug Development2024PMID 39583376

Comparison of Apixaban, Rivaroxaban, Dabigatran, and Vitamin K Antagonists in Patients With Atrial Fibrillation and Liver Disease: A Network Meta-Analysis

Shaikh et al. · Cureus

Added to ASH registry: 2026-05-29

Drug Development2024PMID 38088062

Comparison of bleeding and thrombotic outcomes in veno-venous extracorporeal membrane oxygenation: Heparin versus bivalirudin

Kartika et al. · European journal of haematology

Added to ASH registry: 2026-05-29

Clinical Literature2024PMID 38266751

Comparison of different direct oral anticoagulant regimens in atrial fibrillation patients with high bleeding risk

Ciou et al. · Heart rhythm

Added to ASH registry: 2026-05-29

Drug Development2024PMID 38707166

Comparison of Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban in Patients With Valvular Atrial Fibrillation: A Network Meta-Analysis of Randomized-Control Trials and Observational Studies

Huma et al. · Cureus

Added to ASH registry: 2026-05-29

Clinical Literature2024PMID 39593086

Cost-effectiveness analysis of anticoagulation options for non-valvular atrial fibrillation in Iran

Rezaei et al. · BMC research notes

Added to ASH registry: 2026-05-29

Clinical Literature2024PMID 37884759

Delayed-onset eptifibatide-induced thrombocytopenia

Huffman et al. · American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

Added to ASH registry: 2026-05-29

Drug Development2024PMID 39604509

Detection of enoxaparin and argatroban by use of the novel viscoelastic coagulometer ClotPro

Gratz et al. · Scientific reports

Added to ASH registry: 2026-05-29

Clinical Literature2024PMID 38153164

Diagnosis and management of heparin-induced thrombocytopenia: Third edition

Arachchillage et al. · British journal of haematology

Added to ASH registry: 2026-05-29

Clinical Literature2024PMID 39461853

Direct oral anticoagulant approvals by four major regulatory agencies: a cross-sectional analysis of premarket and postmarket evidence

Mooghali et al. · BMJ open

Added to ASH registry: 2026-05-29

Drug Development2024PMID 36731488

Drug-Drug Interactions in the Treatment of Cancer-Associated Venous Thromboembolism with Direct Oral Anticoagulants

Hellfritzsch et al. · Seminars in thrombosis and hemostasis

Added to ASH registry: 2026-05-29

Drug Development2024PMID 37980264

Editorial: Bivalirudin versus unfractionated heparin in acute myocardial infarction: Why are we still debating?

Cohen et al. · Cardiovascular revascularization medicine : including molecular interventions

Added to ASH registry: 2026-05-29

Drug Development2024PMID 39347284

Edoxaban-Induced Vanishing Bile Duct Syndrome: A Case Report With Review of the Literature

Borgonovo et al. · Cureus

Added to ASH registry: 2026-05-29

Clinical Literature2024PMID 39143401

Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in low-weight patients with atrial fibrillation

Chen et al. · Journal of thrombosis and thrombolysis

Added to ASH registry: 2026-05-29

Clinical Literature2024PMID 38947715

Effectiveness of Novel Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis

Patel et al. · Cureus

Added to ASH registry: 2026-05-29

Drug Development2024PMID 39372148

Esophageal Damage Following Left Atrial Ablation in a Patient on Dabigatran: Adding Insult to Injury

Jalloul et al. · European journal of case reports in internal medicine

Added to ASH registry: 2026-05-29

Showing 40 of 865. The full list is in the research library.

2023

600 articles
Drug Development2023PMID 36478196

A BRIGHT outlook for bivalirudin in patients with ST-segment elevation myocardial infarction

Vergallo et al. · European heart journal

Added to ASH registry: 2026-05-29

Clinical Literature2023PMID 37621412

A neutralizable dimeric anti-thrombin aptamer with potent anticoagulant activity in mice

Nagano et al. · Molecular therapy. Nucleic acids

Added to ASH registry: 2026-05-29

Clinical Literature2023PMID 36928825

An Update in Anticoagulant Therapy for Patients with Cancer-Associated Venous Thromboembolism

Martins et al. · Current oncology reports

Added to ASH registry: 2026-05-29

Drug Development2023PMID 36853326

Analysis of Wholesale Drug Acquisition and Laboratory Assessment Costs Between Heparin Compared With Bivalirudin-Based Systemic Anticoagulation Strategies in Adult Extracorporeal Membrane Oxygenation

Seelhammer et al. · Critical care medicine

Added to ASH registry: 2026-05-29

Drug Development2023PMID 36490373

Anti-thrombotic Therapy With Cangrelor and Bivalirudin in Venoarterial Extracorporeal Membrane Oxygenation Patients Undergoing Percutaneous Coronary Intervention: A Single-Center Experience

Baldetti et al. · ASAIO journal (American Society for Artificial Internal Organs : 1992)

Added to ASH registry: 2026-05-29

Clinical Literature2023PMID 36571839

Anticoagulant Therapy for Cancer-Associated Thrombosis : A Cost-Effectiveness Analysis

Gulati et al. · Annals of internal medicine

Added to ASH registry: 2026-05-29

Clinical Literature2023PMID 37477030

Anticoagulation Management in Temporary Mechanical Circulatory Support Devices

Yin · Texas Heart Institute journal

Added to ASH registry: 2026-05-29

Drug Development2023PMID 37220194

Anticoagulation Stability With Bivalirudin: Positioning the Horse Before the Cart

Chen et al. · ASAIO journal (American Society for Artificial Internal Organs : 1992)

Added to ASH registry: 2026-05-29

Clinical Literature2023PMID 37538041

Anticoagulation strategies in patients with extracorporeal membrane oxygenation: A network meta-analysis and systematic review

Chen et al. · Pharmacotherapy

Added to ASH registry: 2026-05-29

Clinical Literature2023PMID 37818435

Anticoagulation therapy for endocardial/epicardial ablation of infarct-related ventricular tachycardia in a patient with antithrombin deficiency

Hashimoto et al. · Journal of cardiology cases

Added to ASH registry: 2026-05-29

Safety & Infection Control2023PMID 37479891

Antithrombotic secondary prophylaxis with low dose of apixaban or rivaroxaban in the onco-hematologic patients: comparison with non-neoplastic patients

Chistolini et al. · Annals of hematology

Added to ASH registry: 2026-05-29

Drug Development2023PMID 36571840

Apixaban at Apex? Aligning Drug Pricing With Value in Cancer-Associated Thrombosis

Ito et al. · Annals of internal medicine

Added to ASH registry: 2026-05-29

Safety & Infection Control2023PMID 37121015

Apixaban thromboprophylaxis in ambulatory patients with cancer and obesity: Insights from the AVERT trial

Potere et al. · Thrombosis research

Added to ASH registry: 2026-05-29

Clinical Literature2023PMID 37614940

Bioprosthetic valve thrombosis after transcatheter aortic valve replacement and pulmonary embolism due to heparin-induced thrombocytopenia: a case report

Faucher et al. · Frontiers in cardiovascular medicine

Added to ASH registry: 2026-05-29

Drug Development2023PMID 36943709

Bivalirudin Compared to Heparin as the Primary Anticoagulant in Pediatric Berlin Heart Recipients

Freniere et al. · ASAIO journal (American Society for Artificial Internal Organs : 1992)

Added to ASH registry: 2026-05-29

Drug Development2023PMID 37220195

Bivalirudin Superiority in Pediatric Berlin Hearts: Too Early to Draw Conclusions?

Seelhammer et al. · ASAIO journal (American Society for Artificial Internal Organs : 1992)

Added to ASH registry: 2026-05-29

Clinical Literature2023PMID 37598021

Bleeding risk with concomitant administration of VEGF-TKIs and anticoagulant agents

Verso et al. · Seminars in oncology

Added to ASH registry: 2026-05-29

Clinical Literature2023PMID 38077819

Cangrelor for cardiopulmonary bypass in delayed-onset heparin-induced thrombocytopenia: a case report

Durost et al. · Research and practice in thrombosis and haemostasis

Added to ASH registry: 2026-05-29

Clinical Literature2023PMID 39492109

Co-administered oral anticoagulants with nonsteroidal anti-inflammatory drugs and the risk of bleeding: A systematic review and meta-analysis

Zheng et al. · Thrombosis research

Added to ASH registry: 2026-05-29

Drug Development2023PMID 36600413

Comparison of bivalirudin versus heparin in adult extracorporeal membrane oxygenation anticoagulant therapy: A retrospective case-control study

Tong et al. · The International journal of artificial organs

Added to ASH registry: 2026-05-29

Clinical Literature2023PMID 37278934

Direct Oral Anticoagulants for Cancer-Associated Venous Thromboembolism

Masini et al. · Current oncology reports

Added to ASH registry: 2026-05-29

Drug Development2023PMID 37661529

Editorial: Bivalirudin with post-procedural infusion: Should the Guidelines change to keep up with the data?

Lipinski · Cardiovascular revascularization medicine : including molecular interventions

Added to ASH registry: 2026-05-29

Drug Development2023PMID 37058780

Functionalization of PCL-based nanofibers loaded with hirudin as blood contact materials

Zheng et al. · Biomaterials advances

Added to ASH registry: 2026-05-29

Clinical Literature2023PMID 38195304

Immunologic Effects of Heparin Associated With Hemodialysis: Focus on Heparin-Induced Thrombocytopenia

Warkentin · Seminars in nephrology

Added to ASH registry: 2026-05-29

Drug Development2023PMID 37119190

Impact of Bivalirudin on Patients with Acute Coronary Syndrome Undergoing Rotational Atherectomy in Real-Life Setting: A Retrospective Cohort Study

Li et al. · Anatolian journal of cardiology

Added to ASH registry: 2026-05-29

Drug Development2023PMID 37776692

One-year clinical outcomes of bivalirudin versus unfractionated heparin in patients with type 2 diabetes undergoing elective percutaneous coronary intervention

Li et al. · Diabetes & metabolic syndrome

Added to ASH registry: 2026-05-29

Drug Development2023PMID 39076722

One-Year Safety and Effectiveness of Bivalirudin versus Heparin in Patients Undergoing Elective Percutaneous Coronary Intervention

Li et al. · Reviews in cardiovascular medicine

Added to ASH registry: 2026-05-29

Drug Development2023PMID 37170893

Pharmacokinetic drug-drug interactions with direct anticoagulants in the management of cancer-associated thrombosis

Van der Linden et al. · British journal of clinical pharmacology

Added to ASH registry: 2026-05-29

Clinical Literature2023PMID 36574777

Survival Implications of Thrombus Recurrence or Bleeding in Cancer Patients Receiving Anticoagulation for Venous Thromboembolism Treatment

McBane et al. · Thrombosis and haemostasis

Added to ASH registry: 2026-05-29

Drug Development2023PMID 37599483

The effect of bivalirudin on coagulation function in male patients with coronary heart disease undergoing percutaneous coronary intervention

Dequan et al. · Pakistan journal of pharmaceutical sciences

Added to ASH registry: 2026-05-29

Drug Development2023PMID 36821841

Use of Bivalirudin for Chronic Total Occlusion Percutaneous Intervention: Insights From the PROGRESS-CTO Registry

Verreault-Julien et al. · The Journal of invasive cardiology

Added to ASH registry: 2026-05-29

Drug Development2023PMID 37269715

Use of ecarin chromogenic assay during bivalirudin anticoagulation in adult extracorporeal membrane oxygenation

Krauter et al. · Thrombosis research

Added to ASH registry: 2026-05-29

Clinical Literature2023PMID 37525461

'Pearls' of the nineteenth-century: from therapeutic actors to global commodities medicinal leeches in the Ottoman Empire

Arabac. · Medical history

Added to ASH registry: 2026-05-28

Drug Development2023PMID 36705809

30-Day Post-Discharge Prophylaxis with Rivaroxaban Prevents Porto-mesenteric Venous Thrombosis Following Laparoscopic Sleeve Gastrectomy

Swartz et al. · Obesity surgery

Added to ASH registry: 2026-05-28

Drug Development2023PMID 36703578

6-(Arylaminomethyl) Isoquinolines as Enzyme Inhibitors and Their Preparation: A Patent Highlight of Factor XIIa Inhibitors

Al-Horani et al. · Cardiovascular & hematological agents in medicinal chemistry

Added to ASH registry: 2026-05-28

Clinical Literature2023PMID 37940048

A bispecific antibody NXT007 exerts a hemostatic activity in hemophilia A monkeys enough to keep a nonhemophilic state.

Teranishi-Ikawa Y et al. · Journal of thrombosis and haemostasis : JTH

Added to ASH registry: 2026-05-28

Drug Development2023PMID 36947859

A bispecific inhibitor of complement and coagulation blocks activation in complementopathy models via a novel mechanism

Andersen et al. · Blood

Added to ASH registry: 2026-05-28

Clinical Literature2023PMID 36919894

A Case of Argatroban Refractory Heparin Induced Thrombocytopenia and Thrombosis.

Seiler et al. · The American surgeon

Added to ASH registry: 2026-05-28

Clinical Literature2023PMID 37518029

A discussion on the relationship of Capila omeia (Leech, 1894) and C. pseudomeia Fan & Wang, 2004 syn. n. (Hesperiidae, Pyrginae)

Xue et al. · Zootaxa

Added to ASH registry: 2026-05-28

Clinical Literature2023PMID 37902390

A global comparative field study to evaluate the factor VIII activity of efanesoctocog alfa by one-stage clotting and chromogenic substrate assays at clinical haemostasis laboratories.

Pipe et al. · Haemophilia : the official journal of the World Federation of Hemophilia

Added to ASH registry: 2026-05-28

Showing 40 of 600. The full list is in the research library.

2022

559 articles
Clinical Literature2022PMID 36721704

A Review of the Past, Present and Future of Cancer-associated Thrombosis Management

Ramcharitar et al. · Heart international

Added to ASH registry: 2026-05-29

Drug Development2022PMID 36651544

Bivalirudin exerts antiviral activity against respiratory syncytial virus-induced lung infections in neonatal mice

Zhuang et al. · Acta pharmaceutica (Zagreb, Croatia)

Added to ASH registry: 2026-05-29

Drug Development2022PMID 36351460

Bivalirudin in patients with ST-segment elevation myocardial infarction

Coughlan et al. · Lancet (London, England)

Added to ASH registry: 2026-05-29

Drug Development2022PMID 37168321

Bivalirudin Presents a Favorable Safety Profile Regarding Adverse Drug Reactions, Thrombocytopenia, and Bleeding in Chinese Patients With High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Prospective, Multi-Center, Intensive Monitoring Study

Peng et al. · Frontiers in cardiovascular medicine

Added to ASH registry: 2026-05-29

Drug Development2022PMID 36386368

Bivalirudin vs. heparin on a background of ticagrelor and aspirin in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A multicenter prospective cohort study

Yu et al. · Frontiers in cardiovascular medicine

Added to ASH registry: 2026-05-29

Drug Development2022PMID 35752771

Comprehensive safety profile evaluation of bivalirudin in Chinese ST-segment elevation myocardial infarction patients receiving percutaneous coronary intervention: a prospective, multicenter, intensive monitoring study

Zheng et al. · BMC cardiovascular disorders

Added to ASH registry: 2026-05-29

Clinical Literature2022PMID 39077705

Current Status and Future Direction of Antithrombotic Therapy for Patients with STEMI Undergoing Primary PCI

Vogel et al. · Reviews in cardiovascular medicine

Added to ASH registry: 2026-05-29

Clinical Literature2022PMID 36268462

Direct Oral Anticoagulants for the Prevention and Acute Treatment of Cancer-Associated Thrombosis

Attard et al. · Vascular health and risk management

Added to ASH registry: 2026-05-29

Clinical Literature2022PMID 35261295

Direct Oral Anticoagulants for the Treatment of Cancer-Associated Venous Thromboembolism: A Latin American Perspective

Athanazio et al. · Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Added to ASH registry: 2026-05-29

Drug Development2022PMID 35077603

Effectiveness and safety of bivalirudin in elderly patients with coronary artery disease undergoing percutaneous coronary intervention: A real-world study

Li et al. · Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions

Added to ASH registry: 2026-05-29

Drug Development2022PMID 34636772

Efficacy and safety of bivalirudin without post-procedure infusion in patients with coronary heart disease during elective percutaneous coronary intervention: a real-world study

Wang et al. · Chinese medical journal

Added to ASH registry: 2026-05-29

Drug Development2022PMID 35548446

Efficacy and Safety of the Reduced Bivalirudin in Patients Undergoing Coronary Angiography or Percutaneous Coronary Intervention Stratified by Renal Function (REDUCE BOLUS): A Single-Blind, Stratified Randomized, Non-inferiority Trial

Hu et al. · Frontiers in cardiovascular medicine

Added to ASH registry: 2026-05-29

Clinical Literature2022PMID 34479364

How I treat and prevent venous thrombotic complications in patients with lymphoma

Schmidt et al. · Blood

Added to ASH registry: 2026-05-29

Drug Development2022PMID 35942867

Impact of Diabetes Mellitus on One-Year Clinical Outcomes in Patients Anticoagulated with Bivalirudin Undergoing Elective Percutaneous Coronary Intervention

Li et al. · Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Added to ASH registry: 2026-05-29

Drug Development2022PMID 35445577

Low-dose apixaban in extended treatment of cancer-associated thrombosis: Less is more?

Barca-Hernando et al. · Journal of thrombosis and haemostasis : JTH

Added to ASH registry: 2026-05-29

Clinical Literature2022PMID 35235870

Recurrent venous thromboembolism and major bleeding in patients with localised, locally advanced or metastatic cancer: an analysis of the Caravaggio study

Verso et al. · European journal of cancer (Oxford, England : 1990)

Added to ASH registry: 2026-05-29

Clinical Literature2022PMID 36303259

Safe and effective treatment of venous Thromboembolism associated with Cancer: focus on direct Oral Anticoagulants in Asian patients

Lee et al. · Experimental hematology & oncology

Added to ASH registry: 2026-05-29

Drug Development2022PMID 36530956

Safety and Efficacy of Bivalirudin versus Unfractionated Heparin Monotherapy in Patients with CAD and DM Undergoing PCI: A Retrospective Observational Study

Li et al. · Cardiovascular therapeutics

Added to ASH registry: 2026-05-29

Clinical Literature2022PMID 35613184

Survival outcomes with warfarin compared with direct oral anticoagulants in cancer-associated venous thromboembolism in the United States: A population-based cohort study

Khan et al. · PLoS medicine

Added to ASH registry: 2026-05-29

Safety & Infection Control2022PMID 36030069

Thromboprophylaxis of cancer patients undergoing systemic therapy in the ambulatory setting

Ciuffini et al. · Best practice & research. Clinical haematology

Added to ASH registry: 2026-05-29

Antimicrobial Resistance2022PMID 35546572

-Harboring Aeromonas veronii from the Hospital Sewage Samples in China.

Yang C et al. · Microbiology spectrum

Added to ASH registry: 2026-05-28

Antimicrobial Resistance2022PMID 35894056

: Clinical Isolates with High Carbapenem Resistance.

Puah SM et al. · Pathogens (Basel, Switzerland)

Added to ASH registry: 2026-05-28

Clinical Literature2022PMID 35080509

2021 ELSO Adult and Pediatric Anticoagulation Guidelines

McMichael et al. · ASAIO journal (American Society for Artificial Internal Organs : 1992)

Added to ASH registry: 2026-05-28

Clinical Literature2022PMID 35772465

2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19

Farge et al. · The Lancet. Oncology

Added to ASH registry: 2026-05-28

Clinical Literature2022PMID 36039236

A Case of COVID-19 Vaccine-Induced Thrombotic Thrombocytopenia

Harrison et al. · Cureus

Added to ASH registry: 2026-05-28

Clinical Literature2022PMID 36262487

A Case Report and Literature Review on Argatroban Refractory Heparin-Induced Thrombocytopenia

Deen et al. · Journal of community hospital internal medicine perspectives

Added to ASH registry: 2026-05-28

Clinical Literature2022PMID 35924672

A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation: effectiveness and safety of direct oral anticoagulants in the FANTASIIA registry.

Esteve-Pastor et al. · Expert opinion on pharmacotherapy

Added to ASH registry: 2026-05-28

Drug Development2022PMID 35884984

A Factor XIa Inhibitor Engineered from Banded Krait Venom Toxin: Efficacy and Safety in Rodent Models of Arterial and Venous Thrombosis

Chng et al. · Biomedicines

Added to ASH registry: 2026-05-28

Salivary Pharmacology2022PMID 35435721

A Genomic Island of Vibrio cholerae Encodes a Three-Component Cytotoxin with Monomer and Protomer Forms Structurally Similar to Alpha-Pore-Forming Toxins

Herrera A et al. · Journal of bacteriology

Added to ASH registry: 2026-05-28

Antimicrobial Resistance2022PMID 35603723

A high level of antibiotic resistance inandisolates from street water sold in Mozambique, associated with the prevalence of extended-spectrum and AmpC ß-lactamases.

Salamandane A et al. · Journal of environmental science and health. Part. B, Pesticides, food contaminants, and agricultural wastes

Added to ASH registry: 2026-05-28

Clinical Literature2022PMID 34978734

A mathematical estimation for quantified calcium supplementation during intermittent hemodialysis using regional citrate anticoagulation

Bi et al. · Artificial organs

Added to ASH registry: 2026-05-28

Clinical Literature2022PMID 36030390

A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction

Rao et al. · Circulation

Added to ASH registry: 2026-05-28

Genomics & Proteomics2022PMID 34863800

A new species of mammalian trypanosome, Trypanosoma (Megatrypanum) bubalisi sp. nov., found in the freshwater leech Hirudinaria manillensis

Su et al. · International journal for parasitology

Added to ASH registry: 2026-05-28

Genomics & Proteomics2022PMID 35836684

A new species of medicinal leech in the genus Hirudo Linnaeus, 1758 (Hirudiniformes, Hirudinidae) from Tianjin City, China

Wang et al. · ZooKeys

Added to ASH registry: 2026-05-28

Drug Development2022PMID 35551379

A novel inhibitor of Factor XIa as potential haemostasis-sparing anticoagulant for patients with atrial fibrillation

Liuzzo et al. · European heart journal

Added to ASH registry: 2026-05-28

Clinical Literature2022PMID 34859955

A phase I, first-in-human, randomized dose-escalation study of anti-activated factor XII monoclonal antibody garadacimab

McKenzie et al. · Clinical and translational science

Added to ASH registry: 2026-05-28

Drug Development2022PMID 34735741

A proposal for managing bleeding in patients on therapeutic factor XI(a) inhibitors

Salomon et al. · Journal of thrombosis and haemostasis : JTH

Added to ASH registry: 2026-05-28

Clinical Literature2022PMID 35707792

A Rare Case of Extensive Cerebral Venous Sinus Thrombosis Complicated by Heparin-Induced Thrombocytopenia

Jang Khan et al. · Case reports in hematology

Added to ASH registry: 2026-05-28

Clinical Literature2022PMID 35303616

A RIETE registry analysis of patients with upper extremity deep vein thrombosis and thoracic outlet syndrome

Rosa V et al. · Thrombosis research

Added to ASH registry: 2026-05-28

Clinical Literature2022PMID 35472697

A Role of Circuit Clotting and Strategies to Prevent It during Blood Purification Therapy with oXiris Membrane: An Observational Multicenter Study

Villa et al. · Blood purification

Added to ASH registry: 2026-05-28

Showing 40 of 559. The full list is in the research library.

Earlier

5404 articles (pre-2022)
Safety & Infection Control2021PMID 34255597

A comprehensive review of DOACs for cancer associated VTE prophylaxis or treatment

Brea et al. · Postgraduate medicine

Added to ASH registry: 2026-05-29

Clinical Literature2021PMID 33243038

An update on the efficacy and safety of novel anticoagulants for cancer associated thrombosis

Cosmi · Expert opinion on pharmacotherapy

Added to ASH registry: 2026-05-29

Clinical Literature2021PMID 33816032

Anticoagulants Used in Cardiac Catheterization of Patients With Chronic Lymphocytic Leukemia: A Case Report and Overview

Mararenko et al. · Cureus

Added to ASH registry: 2026-05-29

Clinical Literature2021PMID 34053617

Anticoagulation in ST-Elevation Myocardial Infarction

Bavishi et al. · Interventional cardiology clinics

Added to ASH registry: 2026-05-29

Clinical Literature2021PMID 32181569

Antithrombotic regimens for percutaneous coronary intervention of the left main coronary artery: The EXCEL trial

Brener et al. · Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions

Added to ASH registry: 2026-05-29

Clinical Literature2021PMID 39720495

Antithrombotic Therapy in Chronic Total Occlusion Interventions

Xenogiannis et al. · US cardiology

Added to ASH registry: 2026-05-29

Drug Development2021PMID 34425962

Bleeding in Patients With Gastrointestinal Cancer Compared With Nongastrointestinal Cancer Treated With Apixaban, Rivaroxaban, or Enoxaparin for Acute Venous Thromboembolism

Houghton et al. · Mayo Clinic proceedings

Added to ASH registry: 2026-05-29

Clinical Literature2021PMID 34260816

Clinical characteristics and outcomes of incidental venous thromboembolism in cancer patients: Insights from the Caravaggio study

Giustozzi et al. · Journal of thrombosis and haemostasis : JTH

Added to ASH registry: 2026-05-29

Clinical Literature2021PMID 33533929

Comparison Between Non-vitamin K Antagonist Oral Anticoagulants and Low-Molecular-Weight Heparin in Asian Individuals With Cancer-Associated Venous Thromboembolism

Chen et al. · JAMA network open

Added to ASH registry: 2026-05-29

Clinical Literature2021PMID 34410964

Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism in Patients With Active Cancer

Ogata et al. · In vivo (Athens, Greece)

Added to ASH registry: 2026-05-29

Clinical Literature2021PMID 33100017

Direct Oral Anticoagulants in Select Patients With Hypercoagulable Disorders

Valanejad et al. · The Annals of pharmacotherapy

Added to ASH registry: 2026-05-29

Drug Development2021PMID 34447676

Effects of Bivalirudin and Unfractionated Heparin on Liver and Renal Function in Chinese Patients with Coronary Artery Disease Undergoing Coronary Angiography with/without Percutaneous Coronary Intervention

Jia et al. · Journal of clinical and translational hepatology

Added to ASH registry: 2026-05-29

Drug Development2021PMID 34653957

Evaluation of Bivalirudin-Associated Major Adverse Cardiac and Hemorrhagic Events in Acute Coronary Syndrome Patients on Chronic Dialysis Following Percutaneous Coronary Intervention

Fu et al. · The Journal of invasive cardiology

Added to ASH registry: 2026-05-29

Genomics & Proteomics2021PMID 34329918

Function of the waterfowl nests as reproduction and living areas for leeches (Annelida: Hirudinea)

Ceylan et al. · Animal reproduction science

Added to ASH registry: 2026-05-29

Drug Development2021PMID 35573935

Occurrence and Risk Factors of Adverse Drug Reactions in Patients Receiving Bivalirudin as Anticoagulant During Percutaneous Coronary Intervention: A Prospective, Multi-Center, Intensive Monitoring Study

Li et al. · Frontiers in cardiovascular medicine

Added to ASH registry: 2026-05-29

Drug Development2021PMID 33941368

Safety and Effectiveness of Bivalirudin for Perioperative Anticoagulation in a Patient With Hemophilia A Undergoing Percutaneous Coronary Intervention

Luo et al. · The American journal of the medical sciences

Added to ASH registry: 2026-05-29

Drug Development2021PMID 33472252

Safety of Apixaban for Cancer-Associated Thrombosis

Bikdeli et al. · Thrombosis and haemostasis

Added to ASH registry: 2026-05-29

Clinical Literature2021PMID 33254037

Treatment of cancer-associated thrombosis: The evolution of anticoagulant choice and clinical insights into practical management

Riess et al. · Critical reviews in oncology/hematology

Added to ASH registry: 2026-05-29

Clinical Literature2021PMID 33275319

Treatment of Cancer-Associated Venous Thromboembolism with Low-Molecular-Weight Heparin or Direct Oral Anticoagulants: Patient Selection, Controversies, and Caveats

O'Connell et al. · The oncologist

Added to ASH registry: 2026-05-29

Clinical Literature2021PMID 33895845

2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation

Steffel et al. · Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

Added to ASH registry: 2026-05-28

Drug Development2021PMID 33742436

2021 Update of the International Council for Standardization in Haematology Recommendations for Laboratory Measurement of Direct Oral Anticoagulants

Douxfils et al. · Thrombosis and haemostasis

Added to ASH registry: 2026-05-28

Clinical Literature2021PMID 34326300

A 40-Year-Old Man with Sarcoidosis and Factor V Leiden Thrombophilia Presenting with Deep Vein Thrombosis and Pulmonary Thromboembolism.

Goljan-Geremek A et al. · The American journal of case reports

Added to ASH registry: 2026-05-28

Clinical Literature2021PMID 33610318

A case report of successful transition from argatroban to warfarin using DOAC-stop in heparin induced thrombocytopenia (HIT)

Makhija K et al. · Pathology

Added to ASH registry: 2026-05-28

Clinical Literature2021PMID 33580664

A clinical focus on the use of extended-duration thromboprophylaxis in medically ill patients

Snoga et al. · American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

Added to ASH registry: 2026-05-28

Clinical Literature2021PMID 32885714

A comparative analysis of four activated clotting time measurement devices in cardiac surgery with cardiopulmonary bypass

Li et al. · Perfusion

Added to ASH registry: 2026-05-28

Drug Development2021PMID 32883107

A comprehensive appraisal of dabigatran etexilate clinical evidence and applications: a 10-year-long story

Romiti et al. · Future cardiology

Added to ASH registry: 2026-05-28

Drug Development2021PMID 33359646

A direct thrombin inhibitor, dabigatran etexilate protects from renal fibrosis by inhibiting protease activated receptor-1

Saifi et al. · European journal of pharmacology

Added to ASH registry: 2026-05-28

Drug Development2021PMID 33939886

A meta-analysis and cost-minimization analysis of bivalirudin versus heparin in high-risk patients for percutaneous coronary intervention

Sun et al. · Pharmacology research & perspectives

Added to ASH registry: 2026-05-28

Clinical Literature2021PMID 34357657

A meta-analysis evaluating risk factors for compound free flaps for upper extremity defect reconstruction comparing complications and functional outcomes of compound free flaps with and without bone components

Zhang et al. · Microsurgery

Added to ASH registry: 2026-05-28

Drug Development2021PMID 33929388

A Meta-analysis of Clinical Trials Evaluating the Impact of Bivalirudin-based Anticoagulation for Primary Percutaneous Coronary on Long-Term Mortality

Jagadish et al. · Journal of cardiovascular pharmacology

Added to ASH registry: 2026-05-28

Clinical Literature2021PMID 34269872

A new freshwater leech species from Asian Swamp Eel stocks in China

Xu et al. · Parasitology research

Added to ASH registry: 2026-05-28

Clinical Literature2021PMID 33843511

A new subspecies of Trypanosoma cyclops found in the Australian terrestrial leech Chtonobdella bilineata

Ellis et al. · Parasitology

Added to ASH registry: 2026-05-28

Clinical Literature2021PMID 34811021

A proposed order-level classification in Oligochaeta (Annelida, Clitellata)

Schmelz et al. · Zootaxa

Added to ASH registry: 2026-05-28

Safety & Infection Control2021PMID 34689748

A rare case of severe gastroenteritis caused by Aeromonas hydrophila after colectomy in a patient with anti-Hu syndrome: a case report

Greiner M et al. · BMC infectious diseases

Added to ASH registry: 2026-05-28

Clinical Literature2021PMID 34303154

A rechargeable anti-thrombotic coating for blood-contacting devices.

Ham et al. · Biomaterials

Added to ASH registry: 2026-05-28

Clinical Literature2021PMID 33393699

A review of indications and comorbidities in which warfarin may be the preferred oral anticoagulant.

Wadsworth et al. · Journal of clinical pharmacy and therapeutics

Added to ASH registry: 2026-05-28

Drug Development2021PMID 34109658

A synergy of liquid chromatography with high-resolution mass spectrometry and coagulation test for determination of direct oral anticoagulants for clinical and toxicological purposes

Maier et al. · Biomedical chromatography : BMC

Added to ASH registry: 2026-05-28

Drug Development2021PMID 34229946

A systematic review of apixaban in prevention and treatment of cancer-associated venous thromboembolism

Caputo et al. · Journal of the American Pharmacists Association : JAPhA

Added to ASH registry: 2026-05-28

Clinical Literature2021PMID 33814748

A Unique Case of Replantation of Previously Replanted Fingers

Bharathi R et al. · Indian journal of plastic surgery : official publication of the Association of Plastic Surgeons of India

Added to ASH registry: 2026-05-28

Drug Development2021PMID 34519340

Abelacimab and factor XI inhibition: a novel mechanism for the prevention of venous thromboembolism

Narducci et al. · European heart journal

Added to ASH registry: 2026-05-28

Showing 40 of 5404. The full list is in the research library.

Related

Research Roadmap

Open scientific questions ASH is prioritizing for the next research cycle.

View →

Coverage Map

Where ASH's literature coverage is dense and where the gaps remain.

View →

PMID Audit Status

Public transparency report on citation integrity across all ASH registries.

View →

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.

Publication Tracker | ASH